Drug Delivery

Papers
(The H4-Index of Drug Delivery is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Rapid oral transmucosal delivery of zaleplon–lavender oil utilizing self-nanoemulsifying lyophilized tablets technology: development, optimization and pharmacokinetic evaluation117
Development of microparticles for oral administration of Periplaneta americana extract to treat ulcerative colitis101
Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis99
Oral liposomal delivery of an activatable budesonide prodrug reduces colitis in experimental mice92
Hyaluronic acid-based nanoparticles to deliver drugs to the ocular posterior segment90
The development and evaluation of hyaluronic acid coated mitochondrial targeting liposomes for celastrol delivery82
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis80
Advanced hydrogel material for colorectal cancer treatment80
Exploring the effects of cannabidiol encapsulation in liposomes on their physicochemical properties and biocompatibility70
Electroporation induced changes in extracellular vesicle profile59
Transdermal delivery of colchicine using dissolvable microneedle arrays for the treatment of acute gout in a rat model58
Immunomodulatory nano-preparations for rheumatoid arthritis57
Recent progress in nanotechnology-based drug carriers for resveratrol delivery57
Development of a single-dose Q fever vaccine with an injectable nanoparticle-loaded hydrogel: effect of sustained co-delivery of antigen and adjuvant55
Correction55
The role of lipid particle-laden interfaces in regulating the co-delivery of two hydrophobic actives from o/w emulsions51
Cannabidiol lymphatic transport after oral administration assessed using a novel thoracic lymph duct cannulated conscious pig model50
Electrospun PVP/HPBCD nanofiber topical drug delivery platform for enhanced skin permeability and anti-pollution bioactivity of Artocarpus altilis extrac49
Correction49
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats48
Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach47
Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques46
Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements46
Effect and mechanism of paclitaxel loaded on magnetic Fe 3 O 4 @mSiO 245
Microneedle-based injection of Fungizone/Amphotericin B: an effective treatment for American cutaneous leishmaniasis in mice45
Advance in placenta drug delivery: concern for placenta-originated disease therapy45
Exploring the efficacy and constraints of platinum nanoparticles as adjuvant therapy in silicosis management44
Lysosome-directed targeted protein degradation technologies for overcoming cancer drug resistance: mechanisms, design principles, and therapeutic opportunities42
Enhancement of the oral bioavailability of isopropoxy benzene guanidine though complexation with hydroxypropyl-β-cyclodextrin41
Boosting the anti MERS-CoV activity and oral bioavailability of resveratrol via PEG-stabilized emulsomal nano-carrier: Factorial design, in-vitro and in-vivo assessments40
SREKA-targeted liposomes for highly metastatic breast cancer therapy40
Platinum-based drugs and hydrogel: a promising anti-tumor combination39
The development of DNA delivery system based on ionic liquid and carboxylic acid modified polyethyleneimine38
Recent trends in platelet membrane-cloaked nanoparticles for application of inflammatory diseases38
Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective37
Application of chitosan-based drug delivery systems in the treatment of bacterial diseases: a review37
Nanotransethosomes for enhanced transdermal delivery of mangiferin against rheumatoid arthritis: formulation, characterization, invivo pharmacokinetic and pharmacodynamic evaluation37
Tumor microenvironment-responsive conformational activation of apoA-I mimetic peptides for targeted cancer therapy37
PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide37
Disordered mesoporous silica particles: an emerging platform to deliver proteins to the lungs37
0.19384288787842